These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17305577)

  • 41. Design, synthesis, and biological activity of isophthalic acid derivatives targeted to the C1 domain of protein kinase C.
    Boije af Gennäs G; Talman V; Aitio O; Ekokoski E; Finel M; Tuominen RK; Yli-Kauhaluoma J
    J Med Chem; 2009 Jul; 52(13):3969-81. PubMed ID: 19438240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phospholipase A2 products retain a neuron specific gamma isoform of PKC on the plasma membrane through the C1 domain--a molecular mechanism for sustained enzyme activity.
    Yagi K; Shirai Y; Hirai M; Sakai N; Saito N
    Neurochem Int; 2004 Jul; 45(1):39-47. PubMed ID: 15082220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ligand regulation of bovine protein kinase C alpha response via either cysteine-rich repeat of conserved region C1.
    Zhu J; Hansen H; Su L; Shieh HL; Riedel H
    J Biochem; 1994 May; 115(5):1000-9. PubMed ID: 7961586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status and future prospects of C1 domain ligands as drug candidates.
    Boije af Gennäs G; Talman V; Yli-Kauhaluoma J; Tuominen RK; Ekokoski E
    Curr Top Med Chem; 2011; 11(11):1370-92. PubMed ID: 21513495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel "nonkinase" phorbol ester receptors: the C1 domain connection.
    Kazanietz MG
    Mol Pharmacol; 2002 Apr; 61(4):759-67. PubMed ID: 11901214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification, activity, and structural studies of peptides incorporating the phorbol ester-binding domain of protein kinase C.
    Wender PA; Irie K; Miller BL
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):239-43. PubMed ID: 7816824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The C1B domains of novel PKCε and PKCη have a higher membrane binding affinity than those of the also novel PKCδ and PKCθ.
    Egea-Jiménez AL; Corbalán-García S; Gómez-Fernández JC
    Biochim Biophys Acta; 2014 Jul; 1838(7):1898-909. PubMed ID: 24732301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain.
    Rahman GM; Das J
    J Biomol Struct Dyn; 2015; 33(1):219-32. PubMed ID: 24666138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium-independent binding to interfacial phorbol esters causes protein kinase C to associate with membranes in the absence of acidic lipids.
    Mosior M; Newton AC
    Biochemistry; 1996 Feb; 35(5):1612-23. PubMed ID: 8634293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase C.
    Provenzani R; Tarvainen I; Brandoli G; Lempinen A; Artes S; Turku A; Jäntti MH; Talman V; Yli-Kauhaluoma J; Tuominen RK; Boije Af Gennäs G
    PLoS One; 2018; 13(4):e0195668. PubMed ID: 29641588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein kinase C delta (PKC delta): activation mechanisms and functions.
    Kikkawa U; Matsuzaki H; Yamamoto T
    J Biochem; 2002 Dec; 132(6):831-9. PubMed ID: 12473183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells.
    Oancea E; Teruel MN; Quest AF; Meyer T
    J Cell Biol; 1998 Feb; 140(3):485-98. PubMed ID: 9456311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct visualization of the translocation of the gamma-subspecies of protein kinase C in living cells using fusion proteins with green fluorescent protein.
    Sakai N; Sasaki K; Ikegaki N; Shirai Y; Ono Y; Saito N
    J Cell Biol; 1997 Dec; 139(6):1465-76. PubMed ID: 9396752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at the sn-1 and sn-2 positions.
    Kang JH; Benzaria S; Sigano DM; Lewin NE; Pu Y; Peach ML; Blumberg PM; Marquez VE
    J Med Chem; 2006 Jun; 49(11):3185-203. PubMed ID: 16722637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The C2 domain of the Ca(2+)-independent protein kinase C Apl II inhibits phorbol ester binding to the C1 domain in a phosphatidic acid-sensitive manner.
    Pepio AM; Sossin WS
    Biochemistry; 1998 Feb; 37(5):1256-63. PubMed ID: 9477951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intramolecular conformational changes optimize protein kinase C signaling.
    Antal CE; Violin JD; Kunkel MT; Skovsø S; Newton AC
    Chem Biol; 2014 Apr; 21(4):459-469. PubMed ID: 24631122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AI and computational chemistry-accelerated development of an alotaketal analogue with conventional PKC selectivity.
    Maki J; Oshimura A; Tsukano C; Yanagita RC; Saito Y; Sakakibara Y; Irie K
    Chem Commun (Camb); 2022 Jun; 58(47):6693-6696. PubMed ID: 35608215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanding the Paradigm of Structure-Based Drug Design: Molecular Dynamics Simulations Support the Development of New Pyridine-Based Protein Kinase C-Targeted Agonists.
    Lautala S; Provenzani R; Tarvainen I; Sirna K; Karhu ST; Grazhdankin E; Lehtinen AK; Sa'd H; Koivuniemi A; Xhaard H; Tuominen RK; Talman V; Bunker A; Yli-Kauhaluoma J
    J Med Chem; 2023 Apr; 66(7):4588-4602. PubMed ID: 37010933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Charge density influences C1 domain ligand affinity and membrane interactions.
    Kelsey JS; Geczy T; Lewin NE; Kedei N; Hill CS; Selezneva JS; Valle CJ; Woo W; Gorshkova I; Blumberg PM
    Chembiochem; 2014 May; 15(8):1131-1144. PubMed ID: 24777910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentials of PKC in Cancer Progression and Anticancer Drug Development.
    Deka SJ; Trivedi V
    Curr Drug Discov Technol; 2019; 16(2):135-147. PubMed ID: 29468974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.